Skip to main content
ArticleOPEN ACCESS

Corrigendum: New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Biologics: Targets and Therapy, 8, (2014), (221-226)]

Biologics: Targets and Therapy
DOI: 10.2147/BTT.S87768
0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Corrigendum: New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Biologics: Targets and Therapy, 8, (2014), (221-226)]. (2015). Biologics: Targets and Therapy. Dove Medical Press Ltd. https://doi.org/10.2147/BTT.S87768

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free